Biophotonics Discovery: The Podcast

SPIE

Welcome to Biophotonics Discovery: The Podcast, your audio gateway into cutting-edge discoveries and translational advances in biophotonics. Hosted by Biophotonics Discovery, an SPIE journal at the forefront of light-based science and innovation. https://spie.org/biophotonicsdiscovery

  1. Oct 12

    Commercialization in Biophotonics: QUEL Imaging with Ethan LaRochelle and Alberto Ruiz

    What does it take to turn a niche research tool into a thriving business that supports the development of next-generation medical imaging technologies? In this episode of our commercialization series, Darren and Gwen sit down with Ethan LaRochelle and Alberto Ruiz, co-founders of QUEL Imaging to explore the intersection of biophotonics innovation, standardization, and entrepreneurship. Founded while LaRochelle and Ruiz were still graduate students at Dartmouth, QUEL Imaging develops optical tissue phantoms and reference targets that help researchers, device manufacturers, and regulatory teams evaluate the performance of fluorescence imaging systems. The conversation explores the science, standards, and entrepreneurship behind optical phantoms and reference targets for fluorescence imaging. Ethan LaRochelle and Alberto Ruiz discuss how QUEL Imaging helps researchers and medical device companies characterize imaging systems, improve measurement consistency, and support the development of fluorescence-guided surgery and other biomedical optics technologies. They also share the story of building QUEL Imaging from an idea in Brian Pogue's lab into a growing company, offering valuable insights on commercialization, scientific innovation, and bridging the gap between academic research and industry needs. Episode links: Journal of Biomedical Optics, Vol. 31, Issue 7, 077003 blog.quelimaging.com

    Commercialization in Biophotonics: QUEL Imaging with Ethan LaRochelle and Alberto Ruiz
  2. Sep 21

    AI Briefings: Tuning Calcium Signals with Infrared Light: A New Target for Neurostimulation

    Tiny structures called dendritic spines sit at the receiving end of many connections between brain cells, helping neurons communicate and adapt as we learn and form memories. Recent research, reported in Biophotonics Discovery, has illuminated an innovative approach to modulate calcium signaling in neuronal dendritic spines using infrared lasers. Conducted by a team at Vanderbilt Biophotonics Center, the study offers significant insights into how transient photothermal gradients triggered by laser exposure could lead to clinical advancements in neurostimulation. The central question addressed by the researchers was whether infrared neural stimulation (INS) could induce calcium activity specifically within dendritic spines—small protrusions from neurons that are crucial for synaptic transmission. Prior studies have established that infrared light could influence neuronal excitability, but mechanisms underlying calcium dynamics in the context of INS remained largely uncharacterized and INS for dendritic spines has never been studied. To tackle this, the team employed advanced confocal imaging techniques on cortical neurons expressing genetically encoded calcium indicators. These state-of-the-art tools allowed for real-time monitoring of calcium fluctuations in response to targeted laser exposure. The experiments assessed how varying laser parameters—such as pulse duration and temperature—affected calcium signaling in dendritic spines. Read the article: https://www.spiedigitallibrary.org/journals/biophotonics-discovery/volume-3/issue-03/035001/Transient-infrared-laser-exposure-modulates-calcium-activity-in-cortical-dendritic/10.1117/1.BIOS.3.3.035001.full

    AI Briefings: Tuning Calcium Signals with Infrared Light: A New Target for Neurostimulation
  3. Sep 14

    AI Briefings: Exploring Immune Cell Metabolism with Autofluorescence Lifetime Imaging

    A routine blood sample contains a diverse collection of immune cells that can reveal important clues about health and disease. These cells, known as peripheral blood mononuclear cells (PBMCs), are widely used to study infections, autoimmune disorders, cancer, and the immune system's response to treatment. Scientists typically identify these cells using fluorescent labels that attach to specific surface markers. While effective, those methods provide limited information about how the cells function, and can alter the cells during preparation. As reported in Biophotonics Discovery, a recent study shows how advanced optical imaging can reveal the metabolic activity of individual immune cells within a complex blood sample, which was a previously inaccessible layer of information. Senior author Melissa Skala of the Morgridge Institute for Research and the University of Wisconsin–Madison notes, “PBMCs can be isolated clinically easily, and they’re already used in the clinical workflow. The question is, what can we get from them that we aren’t already getting?” That question has growing clinical relevance, as PBMCs are routinely studied in conditions ranging from blood cancers and sepsis, to lupus and cognitive decline. PBMCs also serve as the starting material for cell therapies such as T-cell treatments, where a patient’s own immune cells are harnessed to fight cancer. Understanding not just how many immune cells are present, but how active and metabolically fit they are, could provide new insights into disease progression and treatment response. Read the article: https://www.spiedigitallibrary.org/journals/biophotonics-discovery/volume-3/issue-03/035003/Autofluorescence-lifetime-imaging-resolves-cell-heterogeneity-within-peripheral-blood-mononuclear/10.1117/1.BIOS.3.3.035003.full

    AI Briefings: Exploring Immune Cell Metabolism with Autofluorescence Lifetime Imaging

About

Welcome to Biophotonics Discovery: The Podcast, your audio gateway into cutting-edge discoveries and translational advances in biophotonics. Hosted by Biophotonics Discovery, an SPIE journal at the forefront of light-based science and innovation. https://spie.org/biophotonicsdiscovery